Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women

被引:25
|
作者
Sheu, M
Hogan, J
Allsworth, J
Stein, M
Vlahov, D
Schoenbaum, EE
Schuman, P
Gardner, L
Flanigan, T
机构
[1] Brown Univ, Dept Med, Providence, RI 02912 USA
[2] Ctr Stat Sci, Providence, RI USA
[3] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Wayne State Univ, Dept Med, Detroit, MI 48202 USA
[6] Ctr Dis Control, Atlanta, GA 30333 USA
来源
关键词
D O I
10.1089/15409990260363698
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: Incarceration rates in the United States have tripled over the past two decades and have increased even more rapidly among women than men. To identify risk factors that predict incarceration in HIV-positive (HIV+) and high-risk HIV-negative (HIV-) women and to evaluate the association between continuity of medical care and risk of incarceration, this analysis was conducted. Methods: This was a prospective cohort study of HIV+ and high-risk HIV- women enrolled between April 1993 and January 1995 at four urban centers: Providence, Rhode Island; New York, New York; Baltimore, Maryland; and Detroit, Michigan. The HIV Epidemiology Research (HER) Study enrolled 871 HIV+ and 439 high-risk HIV- innercity women between the ages of 16 and 55 years. All participants had a history of injection drug use or high-risk sexual behavior. Interviews, including questions on continuity of medical care and incarceration, were administered at baseline and 6 and 12 months after enrollment. Any incarceration in the 1-year period following enrollment was the main outcome measure. Continuity of care was measured as having seen one healthcare provider for at least 2 years, having received medical care from one usual physician or clinic, and having obtained medical care in a primary care setting as opposed to an emergency room or drug treatment center. Results: Twelve percent of women were incarcerated within 1 year postenrollment. Factors associated with incarceration included recent drug use, prior incarceration, lack of college education, engaging in sex for drugs or money, and having multiple unmet basic needs at the time of enrollment in the study. Continuity of care with a single healthcare provider for more than 2 years prior to enrollment in the study was associated with decreased rates of incarceration even after adjusting for possible confounding factors (OR = 0.67, 95% CI = 0.48 - 0.92). HIV serostatus did not correlate with incarceration. Conclusions: History of prior incarceration and recent drug use were associated with increased risk of incarceration. Continuity of medical care by a single healthcare provider was associated with decreased likelihood of incarceration, suggesting that the provider may play an important role in designing interventions to prevent incarceration in this high-risk population.
引用
收藏
页码:743 / 750
页数:8
相关论文
共 50 条
  • [31] INSEMINATION OF HIV-NEGATIVE WOMEN WITH PROCESSED SEMEN OF HIV-POSITIVE PARTNERS
    EDLIN, BR
    HOLMBERG, SD
    LANCET, 1993, 341 (8844): : 570 - 571
  • [32] Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative Adults
    Beachler, Daniel C.
    Weber, Kathleen M.
    Margolick, Joseph B.
    Strickler, Howard D.
    Cranston, Ross D.
    Burk, Robert D.
    Wiley, Dorothy J.
    Minkoff, Howard
    Reddy, Susheel
    Stammer, Emily E.
    Gillison, Maura L.
    D'Souza, Gypsyamber
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (01) : 122 - 133
  • [33] High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV- positive women
    Kuguyo, Oppah
    Mandishora, Racheal S. Dube
    Thomford, Nicholas Ekow
    Makunike-Mutasa, Rudo
    Nhachi, Charles F. B.
    Matimba, Alice
    Dandara, Collet
    PLOS ONE, 2021, 16 (09):
  • [34] Allele frequency of three functionally active polymorphisms of the MDR-1 gene in high-risk HIV-negative and HIV-positive Caucasians
    Ifergan, I
    Bernard, NF
    Bruneau, J
    Alary, W
    Tsoukas, CM
    Roger, M
    AIDS, 2002, 16 (17) : 2340 - 2342
  • [35] The Prevalence of High Carcinogenic Risk of HPV Genotypes among HIV-Positive and HIV-Negative MSM from Russia
    Beliakov, Ilia
    Senina, Maria
    Tyulenev, Yuriy
    Novoselova, Elena
    Surovtsev, Viktor
    Guschin, Alexander
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2021, 2021
  • [36] HIGH PREVALENCE OF ORAL HUMAN PAPILLOMAVIRUS (HPV) AMONG HIV-POSITIVE AND HIGH RISK HIV-NEGATIVE ADULTS.
    Beachler, D.
    Gillison, M.
    Strickler, H.
    Burk, R.
    Cranston, R.
    Wiley, D.
    Weber, K.
    Minkoff, H.
    Reddy, S.
    Margolick, J.
    D'Souza, G.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S156 - S156
  • [37] Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men
    Vanable, PA
    Ostrow, DG
    McKirnan, DJ
    Taywaditep, KJ
    Hope, BA
    HEALTH PSYCHOLOGY, 2000, 19 (02) : 134 - 145
  • [38] Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women
    Palefsky, JM
    Minkoff, H
    Kalish, LA
    Levine, A
    Sacks, HS
    Garcia, P
    Young, M
    Melnick, S
    Miotti, P
    Burk, R
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (03): : 226 - 236
  • [39] Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV-positive and HIV-negative women in Rwanda
    Mukanyangezi, M. F.
    Sengpiel, V.
    Manzi, O.
    Tobin, G.
    Rulisa, S.
    Bienvenu, E.
    Giglio, D.
    HIV MEDICINE, 2018, 19 (02) : 152 - 166
  • [40] A description of Kaposi sarcoma risk factors and outcomes in HIV-positive and HIV-negative patients at a tertiary care medical center from 2005 to 2020
    Karissa Libson
    Sonia Himed
    Hayley Dunlop
    Kelsey B. Nusbaum
    Abraham M. Korman
    Benjamin H. Kaffenberger
    John Trinidad
    Archives of Dermatological Research, 2023, 315 : 2159 - 2162